C-Jun NH2-Terminal Kinase Contributes to Dexmedetomidine-Induced Contraction in Isolated Rat Aortic Smooth Muscle

被引:17
作者
Ok, Seong-Ho [1 ]
Jeong, Young Seok [1 ]
Kim, Jae-Gak [1 ]
Lee, Seung-Min [1 ]
Sung, Hui-Jin [1 ]
Kim, Hye Jung [4 ]
Chang, Ki Churl [4 ]
Kwon, Seong-Chun [5 ]
Sohn, Ju-Tae [1 ,2 ,3 ]
机构
[1] Gyeongsang Natl Univ Hosp, Dept Anesthesiol & Pain Med, Jinju 660702, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Jinju, South Korea
[3] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea
[4] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju, South Korea
[5] Kwandong Univ, Coll Med, Dept Physiol, Kangnung, South Korea
关键词
Dexmedetomidine; mitogen-activated protein kinase; alpha(2B)-adrenoceptors; hypertension; rat aorta; ALPHA(1)-ADRENERGIC ANTAGONIST ACTIONS; DUAL ALPHA(2)-ADRENERGIC AGONIST; LIPOXYGENASE PATHWAY ACTIVATION; NITRIC-OXIDE SYNTHESIS; CORONARY HEMODYNAMICS; CALCIUM; CELLS; HYPERTENSION; MEDETOMIDINE; STIMULATION;
D O I
10.3349/ymj.2011.52.3.420
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Dexmedetomidine, a full agonist of alpha(2B)-adrenoceptors, is used for analgesia and sedation in the intensive care units. Dexmedetomidine produces an initial transient hypertension due to the activation of post-junctional alpha(2B)-adrenoceptors on vascular smooth muscle cells (SMCs). The aims of this in vitro study were to identify mitogen-activated protein kinase (MAPK) isoforms that are primarily involved in full, alpha(2B)-adrenoceptor agonist, dexmedetomidine-induced contraction of isolated rat aortic SMCs. Materials and Methods: Rat thoracic aortic rings without endothelium were isolated and suspended for isometric tension recording. Cumulative dexmedetomidine (10(-9) to 10(-6) M) dose-response curves were generated in the presence or absence of extracellular signal-regulated kinase (ERIC) inhibitor PD 98059, p38 MAPK inhibitor SB 203580, c-Jun NH2-terminal kinase (JNK) inhibitor SP 600125, L-type calcium channel blocker (verapamil and nifedipine), and alpha(2)-adrenoceptor inhibitor atipamezole. Dexmedetomidine-induced phosphorylation of ERIC, JNK, and p38 MAPK in rat aortic SMCs was detected using Western blotting. Results: SP 600125 (10(-6) to 10(-5) M) attenuated dexmedetomidine-evoked contraction in a concentration-dependent manner, whereas PD 98059 had no effect on dexmedetomidine-induced contraction. SB 203580 (10(-5) M) attenuated dexmedetomidine-induced contraction. Dexmedetomidine-evoked contractions were both abolished by atipamezole and attenuated by verapamil and nifedipine. Dexmedetomidine induced phosphorylation of JNK and p38 MAPK in rat aortic SMCs, but did not induce phosphorylation of ERIC. Conclusion: Dexmedetomidine-induced contraction involves a JNK- and p38 MAPK-mediated pathway downstream of alpha(2)-adrenoceptor stimulation in rat aortic SMCs. In addition, dexmedetomidine-induced contractions are primarily dependent on calcium influx via L-type calcium channels.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 50 条
  • [31] IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway
    Hashimoto, S
    Gon, Y
    Takeshita, I
    Maruoka, S
    Horie, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (06) : 1001 - 1008
  • [32] Activation of c-Jun NH2-Terminal Kinase 1 Increases Cellular Responsiveness to BMP-2 and Decreases Binding of Inhibitory Smad6 to the Type 1 BMP Receptor
    Liu, Hui
    Liu, Yunshan
    Viggeswarapu, Manjula
    Zheng, Zhaomin
    Titus, Louisa
    Boden, Scott D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (05) : 1122 - 1132
  • [33] Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts:: role of the Jun NH2-terminal kinase
    Frost, RA
    Nystrom, GJ
    Lang, CH
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (05) : R1153 - R1164
  • [34] Involvement of guanosine triphosphatases and phospholipase C-γ2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor
    Hashimoto, A
    Okada, H
    Jiang, A
    Kurosaki, M
    Greenberg, S
    Clark, EA
    Kurosaki, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1287 - 1295
  • [35] Involvement of c-Jun NH2 terminal kinase and p38MAPK in rapamycin-mediated inhibition of neointimal formation in rat carotid arteries
    Omura, T
    Yoshiyama, M
    Izumi, Y
    Kim, S
    Matsumoto, R
    Enomoto, S
    Kusuyama, T
    Nishiya, D
    Nakamura, Y
    Akioka, K
    Iwao, H
    Takeuchi, K
    Yoshikawa, J
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) : 519 - 525
  • [36] NADPH oxidase 4 is required for interleukin-1β-mediated activation of protein kinase Cδ and downstream activation of c-jun N-terminal kinase signaling in smooth muscle
    Ginnan, Roman
    Jourd'heuil, Frances L.
    Guikema, Benjamin
    Simons, Malorie
    Singer, Harold A.
    Jourd'heuil, David
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 54 : 125 - 134
  • [37] The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis
    Zhao, Jiang
    Wang, Liang
    Dong, Xingyou
    Hu, Xiaoyan
    Zhou, Long
    Liu, Qina
    Song, Bo
    Wu, Qingjian
    Li, Longkun
    SCIENTIFIC REPORTS, 2016, 6
  • [38] Cerulein-Induced Acute Pancreatitis Is Associated With c-Jun NH(2)-Terminal Kinase 1-Dependent Ferritin Degradation and Iron-Dependent Free Radicals Formation
    Sledzinski, Maciej
    Borkowska, Andzelika
    Sielicka-Dudzin, Alicja
    Halon, Malgorzata
    Wozniak, Michal
    Spodnik, Jan Henryk
    Antosiewicz, Anna Herman
    Antosiewicz, Jedrzej
    PANCREAS, 2013, 42 (07) : 1070 - 1077
  • [39] Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase
    Jiang, A
    Craxton, A
    Kurosaki, T
    Clark, EA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1297 - 1306
  • [40] (-)-Epigallocatechin-3-gallate decreases thrombin/paclitaxel-induced endothelial tissue factor expression via the inhibition of c-Jun terminal NH2 kinase phosphorylation
    Wang, Huang-Joe
    Lo, Wan-Yu
    Lu, Te-Ling
    Huang, Haimei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 716 - 721